(Q43447911)

23 November 2017

title

Evaluation of circulating endothelial cells, VEGF and VEGFR2 serum levels in patients with chronic myeloproliferative diseases (English)

1 reference

23 November 2017

0 references

2

1 reference

23 November 2017

A Alonci

1

1 reference

23 November 2017

G Bellomo

3

1 reference

23 November 2017

G Penna

4

1 reference

23 November 2017

A D'Angelo

5

1 reference

23 November 2017

E Quartarone

6

1 reference

23 November 2017

C Musolino

7

1 reference

23 November 2017

publication date

1 December 2008

1 reference

23 November 2017

published in

Hematological Oncology

1 reference

23 November 2017

volume

26

1 reference

23 November 2017

issue

4

1 reference

23 November 2017

page(s)

235-239

1 reference

Moving disease biology from the laboratory to the clinic

23 November 2017

cites work

1 reference

Bone marrow stromal cell changes in haematological malignancies

21 January 2018

1 reference

7 January 2021

Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia

1 reference

7 January 2021

Angiogenesis in acute promyelocytic leukemia: induction by vascular endothelial growth factor and inhibition by all-trans retinoic acid

1 reference

7 January 2021

Bone marrow angiogenesis and progression in multiple myeloma.

1 reference

7 January 2021

Bone marrow of patients with active multiple myeloma: angiogenesis and plasma cell adhesion molecules LFA-1, VLA-4, LAM-1, and CD44

1 reference

7 January 2021

Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis.

1 reference

7 January 2021

Resting and activated endothelial cells are increased in the peripheral blood of cancer patients

1 reference

7 January 2021

Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration

1 reference

7 January 2021

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

1 reference

7 January 2021

Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients

1 reference

7 January 2021

Identification of the hemangioblast in postnatal life

1 reference

7 January 2021

Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance.

1 reference

7 January 2021

Circulating endothelial cells in patients with acute myeloid leukemia

1 reference

7 January 2021

Acute myelogenous leukemia--microenvironment interactions: role of endothelial cells and proteasome inhibition.

1 reference

7 January 2021

Circulating endothelial progenitor cells in multiple myeloma: implications and significance

1 reference

7 January 2021

Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion.

1 reference

7 January 2021

Evidence from a leukemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells.

1 reference

7 January 2021

Lymphoma-specific genetic aberrations in microvascular endothelial cells in B-cell lymphomas

1 reference

7 January 2021

In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo

1 reference

7 January 2021

Inhibition of K562 leukemia angiogenesis and growth by expression of antisense vascular endothelial growth factor (VEGF) sequence.

1 reference

7 January 2021

Role of vascular endothelial growth factor (VEGF) and placenta-derived growth factor (PlGF) in regulating human haemopoietic cell growth

1 reference

7 January 2021

Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration

1 reference

7 January 2021

Prognostic significance of cellular vascular endothelial growth factor expression in chronic phase chronic myeloid leukemia

1 reference

7 January 2021

Imatinib mesylate (STI571) decreases the vascular endothelial growth factor plasma concentration in patients with chronic myeloid leukemia.

1 reference

7 January 2021

Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel

1 reference

7 January 2021

The constitutive mobilization of bone marrow-repopulating cells into the peripheral blood in idiopathic myelofibrosis

1 reference

7 January 2021

Increase of CD34 positive cells in polycythaemia vera

1 reference

7 January 2021

Patients with idiopathic myelofibrosis show increased CD34+ cell concentrations in peripheral blood compared to patients with polycythaemia vera and essential thrombocythaemia

1 reference

7 January 2021

Human endothelial cells derived from circulating progenitors display specific functional properties compared with mature vessel wall endothelial cells

1 reference

7 January 2021

Experimental therapy in myelofibrosis with myeloid metaplasia

1 reference

7 January 2021

Myelofibrosis with myeloid metaplasia: new developments in pathogenesis and treatment

1 reference

7 January 2021

The evolving role of lenalidomide in the treatment of hematologic malignancies

1 reference

7 January 2021

Identifiers

DOI

10.1002/HON.865

1 reference

23 November 2017

1 reference